Saturday, August 13, 2022 | Back issues
Courthouse News Service Courthouse News Service

Pharma Class Action

WILMINGTON, Del. - The CEO and other top dogs at Incyte dumped more than $12 million of their shares at inflated prices before they released bad news that made the share price drop by 22% in one day, shareholders claim in Federal Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading
Loading...